Putative tumor suppressor loci at 6q22 and 6q23-q24 are involved in the malignant progression of sporadic endocrine pancreatic tumors

American Journal of Pathology

Volumn 158, Issue 6, 2001, Pages 1903-1911

  Barghorn, André ^a   Speel, Ernst J M ^a,b   Farspour, Bita ^a   Saremaslani, Parvin ^a   Schmid, Sonja ^a   Perren, Aurel ^a   Roth, Jürgen ^c   Heitz, Philipp U ^a   Komminoth, Paul ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c Kantonsspital Baden   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CARCINOGENESIS; CHROMOSOME 6Q; CHROMOSOME DELETION; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FREQUENCY; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; MARKER GENE; PANCREAS ISLET CELL TUMOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

EID: 0034970550     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64658-5     Document Type: Article

References (45)

1. The endocrine pancreas
2. Human insulinoma: Clinical, cellular, and molecular aspects
3. Positional cloning of the gene for multiple endocrine neoplasia-type 1
4. Identification of the von Hippel-Lindau disease tumor suppressor gene
5. Somatic mutations of the MEN 1 tumor suppressor gene in sporadic gastrinomas and insulinomas
6. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors
7. Mutations and allelic deletions of the MEN 1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms
8. A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications
9. Pancreatic endocrine tumours: Evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p
10. Deletion at 3p25.3-p23 is frequently encountered in endocrine pancreatic tumors and is associated with metastatic progression
11. Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors
12. Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors
13. Deletion of chromosome 1 predicts prognosis in pancreatic endocrine tumors
14. Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization
15. Clonal analysis of sporadic pancreatic endocrine tumours
16. Mixed medullary-follicular thyroid carcinoma: Molecular evidence for a dual origin of tumor components
17. MEN 1 gene mutation analysis of sporadic adrenocortical lesions
18. Isolation and mapping of 68 RFLP markers on human chromosome 6
19. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas
20. Different genomic aberrations in small (D ≤ 2cm) functioning and non-functioning endocrine pancreatic tumors
21. Isolation and characterization of genes associated with chromosome 6 mediated tumor suppression in human malignant melanoma
22. AIM1, a novel non-lens member of the beta-gamma-crystillin superfamily, is associated with the control of tumorigenicity in human malignant melanoma
23. Molecular cloning and chromosomal localization of the human cyclin C (CCNC) and cyclin E (CCNE) genes: Deletion of the CCNC gene in human tumors
24. Cyclin C is a primary 1alpha,25-dihydroxyvitamin D(3) responding gene
25. Transforming growth factor-beta 1 inhibits human keratinocyte proliferation by upregulation of a receptor-type tyrosine phosphatase R-PTP-kappa gene expression
26. Cytogenetical assignment and physical mapping of the human R-PTP-kappa gene (PTPRK) to the putative tumor suppressor gene region 6q22.2-q22.3
27. Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6
28. Association of human protein-tyrosine phosphatase κ with members of the armadillo family
29. Identification of a gene containing zinc-finger motifs based on lost expression in malignantly transformed rat ovarian surface epithelial cells
30. hZAC encodes a zinc finger protein with antiproliferative properties and maps to a chromosomal region frequently lost in cancer
31. The cell cycle control gene ZAC/PLAGL1 is imprinted - A strong candidate gene for transient neonatal diabetes
32. A human melanoma metastasis-suppressor locus maps to 6q16.3-q23
33. A refined localization of two deleted regions in chromosome 6q associated with salivary gland carcinomas
34. A novel region of deletion on chromosome 6q23.3 spanning less than 500 kb in high grade invasive epithelial ovarian cancer
35. Allelic loss on chromosome 6q in primary prostate cancer
36. Substantial reduction of the gastric carcinoma critical region at 6q16.3-q23.1
37. Comprehensive allelotype study of hepatocellular carcinoma: Potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors
38. Frequent loss of heterozygosity on the long arm of chromosome 6: Identification of two distinct regions of deletion in childhood acute lymphoblastic leukemia
39. Identification of three commonly deleted regions on chromosome arm 6q in human pancreatic cancer
40. The molecular genetics of pancreatic cancer
41. Cytogenetic and CGH studies of four neuroendocrine tumors and tumor-derived cell lines of a patient with multiple endocrine neoplasia type 1
42. Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas
43. Losses of chromosomes 1p and 3q are early genetic events in the development of sporadic pheochromocytomas
44. Analysis of genomic alterations in sporadic adrenocortical lesions: Gain of chromosome 17 is an early event in adrenocortical tumorigenesis